the importance of risk-adapted therapies in hodgkin lymphoma
Published 1 year ago • 80 plays • Length 1:17Download video MP4
Download video MP3
Similar videos
-
1:27
diagnosis and risk stratification in hodgkin lymphoma: updates and novel approaches
-
2:42
the current role of chemotherapy in the treatment of hodgkin lymphoma & the impact of novel agents
-
2:22
the importance of assessing cardiac risk in patients undergoing treatment for hl
-
2:03
novel therapeutic agents in the treatment of hodgkin and non-hodgkin lymphoma
-
1:50
considerations for risk-adapted therapy in lower-risk mds
-
6:24
tnb-486: interim results of a cd19/cd3 t-cell engager in r/r follicular lymphoma
-
10:17
risk-based quality management (rbqm) video series – part 1
-
10:55
what is risk management? | risk management process
-
1:29
updates on the diagnosis, risk stratification and management of hl
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
1:56
optimal therapy sequencing for hodgkin lymphoma
-
2:13
risk stratification and personalized treatment in hl
-
1:09
novel immunotherapy combinations in hodgkin lymphoma
-
1:29
risk-adapted therapy of aml
-
1:37
a prospective trial of radiation-free chemotherapy in high- and low-risk hl
-
1:20
the current standard of care for patients with lower-risk mds
-
1:59
hodgkin lymphoma: prognostic markers in the era of novel treatments
-
3:05
the benefits of pet in the prognosis and treatment of hl
-
2:02
unmet needs in high-risk mds and future therapeutic strategies
-
3:07
keynote-204 in r/r classical hodgkin lymphoma
-
4:00
immunotherapies for the treatment of high-risk mm
-
1:21
novel approaches to harnessing the immune system in lymphoma